The fund will make pre-seed up to series A investments, also providing firms with strategic support and access to international networks to attract further investment.
Aerska develops RNA medicines for the treatment of neurological diseases such as Parkinson’s and Alzheimer’s, which affect millions of people worldwide.
After a tough start to the year, confidence has returned among impact founders and investors in Europe, a new report by Swedish venture capitalist Norrsken VC said.
The Swiss impact asset manager made its first climate infrastructure investment in Latin America and also provided funding to one of Southeast Asia’s leading fruit processing and export companies.
Nature finance is gaining momentum, but the complexity of the sector often leaves nature underpriced, undervalued and underfinanced, a new report has said.
VoLo Earth’s latest fund attracted investments from a range of global financial institutions, funds and family offices, bucking a downward trend in venture capital fundraising.
PGGM made the investment on behalf of client PFWZ, the pension fund for the Dutch health and welfare sector, which has allocated €1bn to the energy transition over the next five years.